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The Picornaviridae family contains a large number of human pathogens such as
rhinovirus, poliovirus and hepatitis A virus (HAV). Hepatitis A is an infectious
disease that causes liver inflammation. It is highly endemic in developing
countries with poor sanitation, where infections often occur in children. As in
other picornaviruses, the genome of HAV contains one open reading frame
encoding a single polyprotein that is subsequently processed by viral proteinases
to originate mature viral proteins during and after the translation process. In the
polyprotein, the N-terminal P1 region generates the four capsid proteins, while
the C-terminal P2 and P3 regions contain the enzymes, precursors and accessory
proteins essential for polyprotein processing and virus replication. Here, the first
crystals of protein 2AB of HAV are reported. The crystals belonged to space
group P41 or P43, with unit-cell parameters a = b = 90.42, c = 73.43 A˚, and
contained two molecules in the asymmetric unit. Native and selenomethionine-
derivative crystals diffracted to 2.7 and 3.2 A˚ resolution, respectively.
1. Introduction
Hepatitis A virus (HAV), transmitted by the faecal–oral route, is a
common cause of acute hepatitis worldwide. As a member of the
Picornaviridae family, HAV possesses a nonenveloped icosahedral
capsid of 30 nm in diameter which encapsidates a positive-sense
single-stranded RNA genome of approximately 7.5 kb covalently
linked to a VPg peptide (Weitz et al., 1986). Nevertheless, HAV is
biologically distinct from other picornaviruses as the infections that it
causes are characterized by slow viral replication and the absence of
induced cellular lysis. Another distinct feature of HAV is that it has
developed a highly deoptimized codon usage. This strategy is thought
to play a role in escaping the host-cell defences, allowing the virus to
grow in a quiescent way (Pinto´ et al., 2007). Thus, HAV presents very
low translation and RNA-replication activity (Harmon et al., 1989;
Wheeler et al., 1986).
The HAV genome codes for a single polyprotein, which is cleaved
into mature proteins by the viral proteinase 3Cpro and host proteases
(Schultheiss et al., 1994). This polyprotein precursor is organized into
three regions named P1, P2 and P3. The P2 region comprises proteins
2A, 2B and 2C. HAV 2A (71 amino acids in length) has no sequence
similarity to any other picornaviral protein and lacks proteolytic
activity (Hollinger & Emerson, 2007). The 2A region within the
precursor VP1-2A plays an essential role in early particle assembly as
it is required for the formation of the pentamer intermediates (Cohen
et al., 2002; Morace et al., 2008). Typical picornavirus 2B proteins
(28 kDa) are membrane-associated proteins with a hydrophobic
region containing a conserved putative amphiphatic -helix at their
C-terminus (de Jong et al., 2008; van Kuppeveld et al., 1996). The
HAV 2B protein is approximately 100 amino acids longer than those
of other picornaviruses and also appears to be involved in membrane
rearrangements during HAV infection (Gosert et al., 2000; Jecht et al.,
1998). No structural information is available for any picornaviral 2B
protein. In this paper, we report the cloning, expression, purification
and preliminary X-ray crystallographic studies of the nonstructural
region 2AB of HAV. Native and selenomethionine-derivative crystals
diffracted to 2.7 and 3.2 A˚ resolution, respectively, and were suitable
for three-dimensional structure determination.
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2. Materials and methods
2.1. Transmembrane-helix prediction
The described interaction of HAV 2B protein with cellular mem-
branes makes its heterologous expression, purification and crystal-
lization considerably more difficult. In order to localize the region(s)
responsible for this interaction, the 2B amino-acid sequence was
analyzed using different servers for the prediction of transmembrane
helices [TMHMM v.2.0 (Krogh et al., 2001), TMpred (Hofmann &
Stoffel, 1993) and SOSUI (Hirokawa et al., 1998)]. These servers
predicted the existence of a transmembrane helix approximately
spanning residues 1012–1031. This information was taken into
account in the experimental design, avoiding the inclusion of this
putative transmembrane region in the cloned sequence.
2.2. Cloning
HAV codon usage is not appropriate for the heterologous over-
expression of its proteins in Escherichia coli. To override this
problem, a synthetic gene covering 217 residues (23 kDa) of the
HAV polyprotein (residues 765–981 from GenBank accession No.
M14707.1; Cohen et al., 1987) and including flanking sequences that
provide 50 NdeI and 30 SapI restriction sites was generated. The
coding sequence corresponds to the full-length 2A protein (71 resi-
dues) and the N-terminal domain of the 2B protein (146 residues; the
soluble portion). To this end, 34 DNA oligonucleotides (of between
32 and 47 nucleotides in length) were designed with the program
DNAWorks (Hoover & Lubkowski, 2002; Supplementary Table 11)
and were used in PCR-based gene assembly using Pfu polymerase
(Promega) essentially according to Stemmer et al. (1995). In brief, the
oligonucleotide mixture (2 mM each) was used in an assembly PCR
reaction (heating at 368 K for 3 min prior to 45 cycles of 1 min at
368 K, 1 min at 330 K and 1 min at 345 K) followed by an amplifi-
cation reaction (30 cycles of 1 min at 368 K, 1 min at 338 K and 1 min
at 345 K) using the two outermost oligonucleotides as primers. The
resulting PCR product (approximately 680 bp) was cloned into
pGEM-T Easy (Promega), sequenced and subcloned into the NdeI
and SapI sites of expression vector pTYB1 (New England Biolabs),
leading to an ORF coding for HAV 2AB with a C-terminal intein tag
(55 kDa) which allows its purification by affinity chromatography
(IMPACT system; Chong et al., 1998).
2.3. Expression and purification
E. coli BL21 (DE3) cells were transformed with the expression
plasmid and cultures were grown in Luria–Bertani medium supple-
mented with 100 mg ml1 ampicillin at 303 K until the OD600 reached
0.3 and then cooled to 285 K. At an OD600 of 0.5 the cultures were
induced with 0.3 mM isopropyl -d-1-thiogalactopyranoside (IPTG)
and incubated for a further 17 h at 285 K, after which the cells were
harvested by centrifugation. The pelleted cells were resuspended in
cold lysis buffer (20 mM Na HEPES pH 8.5, 500 mM NaCl, 1 mM
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Table 1
Data-collection and processing statistics.
Values in parentheses are for the outermost resolution shell.
Selenomethionine derivative
Native 1 2 1 and 2 combined
Wavelength (A˚) 0.873 0.873 0.873 0.873
Temperature (K) 100 100 100 100
Space group P43 P43 P43 P43
Unit-cell parameters (A˚)
a = b 90.4 90.2 90.4 90.3
c 73.4 73.2 73.2 73.2
Resolution range (A˚) 57.0–2.70 (2.85–2.70) 63.0–3.30 (3.48–3.30) 56.7–3.20 (3.37–3.20) 63.9–3.20 (3.37–3.20)
Molecules in asymmetric unit 2 2 2 2
Solvent content (%) 59.0 58.7 58.9 58.8
Matthews coefficient (A˚3 Da1) 3.00 2.98 2.99 2.98
’ () 1 3 3 3
No. of collected frames 100 300 300 600
Reflections (observed/unique) 54920/13343 609356/11920 436072/11963 1045428/11920
Completeness (%) 81.0 (62.9) 100 (100) 99.9 (100) 100 (100)
I/(I) 4.1 (2.3) 3.9 (1.6) 4.7 (1.8) 3.8 (1.6)
Mean I/(I) 8.9 (2.0) 14.9 (3.0) 19.2 (6.3) 27.3 (6.7)
Multiplicity 2.4 (1.3) 18.3 (5.4) 20.7 (13.1) 38.9 (18.6)
Rmerge† 0.10 (0.27) 0.17 (0.47) 0.14 (0.41) 0.17 (0.45)
Rp.i.m.‡ 0.07 (0.27) 0.06 (0.35) 0.04 (0.16) 0.04 (0.15)
Anomalous completeness (%) — 100 (99.7) 99.7 (98.7) 100 (100)
Anomalous multiplicity — 9.3 (2.7) 10.6 (6.6) 19.9 (9.4)
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the observed intensity and hI(hkl)i is the average intensity of multiple observations of symmetry-related
reflections. ‡ Rp:i:m: ¼
P
hkl ½1=ðN  1Þ1=2
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where Ii(hkl) is the observed intensity and hI(hkl)i is the average intensity of multiple observations of
symmetry-related reflections.
Figure 1
Crystals of HAV 2AB protein. Scale bar: 100 mm.
1 Supplementary material has been deposited in the IUCr electronic archive
(Reference: PU5340).
EDTA, 1 mM PMSF, 20 mg ml1 DNase I) and lysed by sonication
on ice. The soluble fraction was then obtained by centrifugation and
loaded onto a 5 ml column packed with Chitin Beads (New England
Biolabs). After extensive washing with buffer A (20 mM Na HEPES
pH 8.5, 500 mM NaCl, 1 mM EDTA), the 2AB protein was eluted
from the column with buffer A supplemented with 50 mM DTT. The
eluted protein was further purified by size-exclusion chromatography
on a HiPrep 16/60 Sephacryl S-100 HR column (GE Healthcare)
equilibrated in buffer A containing 5 mM DTT. Pure 2AB protein
was then concentrated to 6.5 mg ml1 using a Vivaspin concentrator
(10 000 MWCO PES, Sartorius Stedim Biotech).
To produce selenomethionine-containing 2AB, E. coli B834 (DE3)
cells were transformed with the expression plasmid and grown over-
night in 100 ml minimal medium (SelenoMet, Molecular Dimensions)
supplemented with 4 mg l1 l-methionine. Prior to induction, the
cells were harvested and washed three times in 100 ml sterile water.
The cell pellet was then resuspended in 1 ml sterile water and used
to inoculate 2 l prewarmed (285 K) minimal medium containing 1
l-SeMet (prepared according to the manufacturer’s instructions from
250 SelenoMethionine Solution, Molecular Dimensions). All other
procedures were as described for the nonlabelled protein.
2.4. Crystallization
Preliminary crystallization conditions were explored using the
sitting-drop vapour-diffusion method at both 277 and 293 K in
96-well plates (MRC, Swissci AG) using an automated drop dispenser
(Phoenix/RE, Rigaku) to mix 150 nl protein solution (6.5 mg ml1)
with an equal volume of reservoir solution. Small crystals of HAV
2AB were observed with reservoir conditions consisting of 0.1M
MES pH 6 and 1.26M ammonium sulfate at 293 K.
This condition was refined and crystals were finally grown at 277 K
in 24-well VDX plates (Hampton Research) in drops obtained
by mixing identical volumes (0.5 or 0.75 ml) protein solution
(6.5 mg ml1) and reservoir solution (0.1M MES pH 5.2–5.8, 1.26M
ammonium sulfate, 5 mM DTT) and equilibrated against a 750 ml
reservoir. Small tetragonal crystals (0.02 mm per edge) were obtained
within between one and four weeks (Fig. 1). Selenomethionine-
substituted protein crystals were grown using the same conditions as
for the native protein.
2.5. X-ray diffraction analysis
Crystals were harvested in CryoLoops (Hampton Research) and
soaked for 1 min in the crystallization solution supplemented with
20%(v/v) glycerol. Mounted crystals were flash-cooled by immersion
in liquid nitrogen. X-ray diffraction data sets were collected from
both native and selenomethionine-substituted crystals with an ADSC
Q315R detector on beamline ID23-EH2 at the European Synchro-
tron Radiation Facility (ESRF; Grenoble, France) using a 14.20 keV
( = 0.873 A˚) beam focused to 10 mm. A total of 100 frames were
recorded at 100 K using an oscillation angle of 1, 1 s exposure time
per frame and a crystal-to-detector distance of 334.07 mm (Fig. 2).
Data sets were indexed and integrated usingMOSFLM (Leslie, 1991)
and scaled, merged and reduced with SCALA (from CCP4; Winn et
al., 2011). Although the data sets obtained from selenomethionine-
substituted crystals were sufficiently complete, the two best data sets
were merged using CAD (from CCP4; Winn et al., 2011) and scaled
together in order to increase the anomalous signal multiplicity at high
resolution (Table 1).
3. Results and discussion
The overexpression of HAV 2AB protein for crystallization purposes
presented two major complications. Firstly, the HAV 2B protein has
been reported to associate with cellular membranes (Gosert et al.,
2000; Jecht et al., 1998). Moreover, HAV genes have an unusually
high frequency of rare codons, leading to low rates of protein
synthesis (Pinto´ et al., 2007). Sequence analysis allowed the identifi-
cation of a putative transmembrane helix at the C-terminus of 2B
(residues 1012–1031). This region was omitted from the expression
construct to avoid the complications associated with the expression
and purification of membrane proteins. Furthermore, to overcome
the problems derived from HAV codon usage, a synthetic gene was
generated. This new sequence codes for the same polypeptide as the
region of interest of the HAV genome (residues 765–981 of the P2
polyprotein region) but displays E. coli codon usage. Decreasing the
E. coli growth temperature to 285 K during protein expression was
crucial for obtaining soluble recombinant HAV 2AB and ultimately
for obtaining crystals (Fig. 1).
Despite the small size of the crystals (20 mm per edge), a com-
plete data set was collected to 2.7 A˚ resolution from a single native
crystal using synchrotron radiation on the microfocus beamline ID23-
EH2 of the ESRF. The final data-collection and processing statistics
are summarized in Table 1. Analysis of systematic absences indicated
that the crystal belonged to space group P41 or P43. Phase determi-
nation (see below) allowed the identification of P43 as the correct
space group. The volume of the crystal asymmetric unit is compatible
with the presence of two 2AB molecules, with a Matthews coefficient
of 3.0 A˚3 Da1 and a calculated solvent content of 59.0% (Matthews,
1968).
Phase determination by molecular-replacement methods was
initially attempted using the available structures of rhinovirus and
enterovirus 2A proteins as starting models (PDB entries 2hrv and
1z8r; Petersen et al., 1999; Baxter et al., 2006). This approach was
unsuccessful, probably owing to the lack of homology between the
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Figure 2
X-ray diffraction pattern of the HAV 2AB crystals. The detector was set to an edge
resolution of 2.70 A˚ (the resolution at the corner was 1.98 A˚). Diffraction spots
were observed to 2.25 A˚ resolution.
2A region of HAV and the available picornaviral 2A proteinases
(Hollinger & Emerson, 2007).
Using the SAD data (Table 1), we have determined the positions of
all Se atoms (12, in the asymmetric unit). Model building is ongoing.
References
Baxter, N. J., Roetzer, A., Liebig, H. D., Sedelnikova, S. E., Hounslow, A. M.,
Skern, T. & Waltho, J. P. (2006). J. Virol. 80, 1451–1462.
Chong, S., Montello, G. E., Zhang, A., Cantor, E. J., Liao, W., Xu, M.-Q. &
Benner, J. (1998). Nucleic Acids Res. 26, 5109–5115.
Cohen, J. I., Ticehurst, J. R., Purcell, R. H., Buckler-White, A. & Baroudy,
B. M. (1987). J. Virol. 61, 50–59.
Cohen, L., Be´nichou, D. & Martin, A. (2002). J. Virol. 76, 7495–7505.
Gosert, R., Egger, D. & Bienz, K. (2000). Virology, 266, 157–169.
Harmon, S. A., Summers, D. F. & Ehrenfeld, E. (1989). Virus Res. 12, 361–369.
Hirokawa, T., Boon-Chieng, S. & Mitaku, S. (1998). Bioinformatics, 14,
378–379.
Hofmann, K. & Stoffel, W. (1993). Biol. Chem. Hoppe-Seyler, 374, 166.
Hollinger, F. B. & Emerson, S. U. (2007). Fields’ Virology, edited by D. M.
Knipe & P. M. Howley, pp. 911–947. Philadelphia: Lippincott, Williams &
Wilkins.
Hoover, D. M. & Lubkowski, J. (2002). Nucleic Acids Res. 30, e43.
Jecht, M., Probst, C. & Gauss-Mu¨ller, V. (1998). Virology, 252, 218–227.
Jong, A. S. de, de Mattia, F., Van Dommelen, M. M., Lanke, K., Melchers, W. J.,
Willems, P. H. & van Kuppeveld, F. J. (2008). J. Virol. 82, 3782–3790.
Krogh, A., Larsson, B., von Heijne, G. & Sonnhammer, E. L. (2001). J. Mol.
Biol. 305, 567–580.
Kuppeveld, F. J. van, Galama, J. M., Zoll, J., van den Hurk, P. J. & Melchers,
W. J. (1996). J. Virol. 70, 3876–3886.
Leslie, A. G. W. (1991). Crystallographic Computing 5: From Chemistry to
Biology, edited by D. Moras, A. D. Podjarny & J. C. Thierry, pp. 27–38.
Oxford University Press.
Matthews, B. W. (1968). J. Mol. Biol. 33, 499–501.
Morace, G., Kusov, Y., Dzagurov, G., Beneduce, F. & Gauss-Muller, V. (2008).
BMB Rep. 41, 678–683.
Petersen, J. F., Cherney, M. M., Liebig, H. D., Skern, T., Kuechler, E. & James,
M. N. (1999). EMBO J. 18, 5463–5475.
Pinto´, R. M., Aragone`s, L., Costafreda, M. I., Ribes, E. & Bosch, A. (2007).
Virus Res. 127, 158–163.
Schultheiss, T., Kusov, Y. Y. & Gauss-Mu¨ller, V. (1994). Virology, 198, 275–281.
Stemmer, W. P., Crameri, A., Ha, K. D., Brennan, T. M. & Heyneker, H. L.
(1995). Gene, 164, 49–53.
Weitz, M., Baroudy, B. M., Maloy, W. L., Ticehurst, J. R. & Purcell, R. H.
(1986). J. Virol. 60, 124–130.
Wheeler, C. M., Fields, H. A., Schable, C. A., Meinke, W. J. & Maynard, J. E.
(1986). J. Clin. Microbiol. 23, 434–440.
Winn, M. D. et al. (2011). Acta Cryst. D67, 235–242.
crystallization communications
Acta Cryst. (2011). F67, 1224–1227 Garriga et al.  2AB protein 1227
